Overview

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
To determine if carbon ion radiotherapy improves overall survival versus photon therapy in patients with locally advanced, unresectable pancreatic cancer
Phase:
Phase 3
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Treatments:
Albumin-Bound Paclitaxel
Gemcitabine
Paclitaxel